Bayer Aktiengesellschaft / Key word(s): Strategic Company Decision 18.09.2014 08:51 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Leverkusen, September 18, 2014 The Board of Management of Bayer AG plans to focus the Bayer Group entirely on the Life Science businesses - HealthCare and CropScience - and float MaterialScience on the stock market as a separate company. In this way Bayer would position itself as a world-leading company in the field of human, animal and plant health. The plans remain subject to the approval of the Supervisory Board. The Board of Management decided this on September 2, 2014. The Supervisory Board of Bayer AG will discuss the plans at its meeting today, Thursday. It is planned to release further information when the Supervisory Board has reached its decision. Contact: Peter Dahlhoff, Bayer AG, Investor Relations, Phone: 0214-30-33022, e-mail: peter.dahlhoff@bayer.com, Fax: +49-214-30-96-33022 --------------------------------------------------------------------------- Information and Explaination of the Issuer to this News: Forward-Looking Statements This Ad-hoc Statement may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments. 18.09.2014 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Bayer Aktiengesellschaft Kaiser-Wilhelm-Allee 1 51373 Leverkusen Germany Phone: +49 (0)214 30-81 013 Fax: +49 (0)21430-9681013 E-mail: Internet: www.bayer.com ISIN: DE000BAY0017 WKN: BAY001 Indices: DAX, EURO STOXX 50, Stoxx 50 Listed: Regulierter Markt in Berlin, Düsseldorf, Frankfurt (Prime Standard), Hamburg, Hannover, München, Stuttgart; Terminbörse EUREX; Madrid End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-Adhoc: Bayer Aktiengesellschaft: Bayer Board of Management plans to focus entirely on Life Science businesses
| Source: EQS Group AG